MISX:APTK

Stock Analysis Report

Executive Summary

Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Share Price & News

How has Pharmacy Chain 36.6's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: APTK has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-0.07%

APTK

-0.6%

RU Consumer Retailing

-1.9%

RU Market


1 Year Return

161.7%

APTK

5.5%

RU Consumer Retailing

20.6%

RU Market

Return vs Industry: APTK exceeded the Russian Consumer Retailing industry which returned 5.5% over the past year.

Return vs Market: APTK exceeded the Russian Market which returned 20.6% over the past year.


Shareholder returns

APTKIndustryMarket
7 Day-0.07%-0.6%-1.9%
30 Day0.02%0.7%4.6%
90 Day4.2%5.8%8.9%
1 Year161.7%161.7%9.8%5.5%29.4%20.6%
3 Year10.0%10.0%6.0%-4.2%63.2%37.7%
5 Year-17.4%-17.4%18.1%0.06%152.5%98.1%

Price Volatility Vs. Market

How volatile is Pharmacy Chain 36.6's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Pharmacy Chain 36.6 undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Pharmacy Chain 36.6 is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Pharmacy Chain 36.6 has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of APTK’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Pharmacy Chain 36.6 regulatory filings.
  • Explore potentially undervalued companies in the Consumer Retailing industry.

Future Growth

How is Pharmacy Chain 36.6 forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.7%

Forecasted Consumer Retailing industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pharmacy Chain 36.6 has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Pharmacy Chain 36.6 performed over the past 5 years?

-49.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: APTK has large one-off items impacting its financial results.

Growing Profit Margin: APTK is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: APTK is unprofitable, and losses have increased over the past 5 years at a rate of -49.4% per year.

Accelerating Growth: Unable to compare APTK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: APTK is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (0.5%).


Return on Equity

High ROE: APTK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Pharmacy Chain 36.6's financial position?


Financial Position Analysis

Short Term Liabilities: APTK has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: APTK has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: APTK has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: APTK's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: APTK has a high level of physical assets or inventory.

Debt Coverage by Assets: APTK has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: APTK has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: APTK has less than a year of cash runway if free cash flow continues to reduce at historical rates of -29.6% each year


Next Steps

Dividend

What is Pharmacy Chain 36.6's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%3.6%markettop25%8.9%industryaverage3.5%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate APTK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate APTK's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if APTK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if APTK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of APTK's dividend in 3 years as they are not forecast to pay a notable one for the Russian market.


Next Steps

Management

What is the CEO of Pharmacy Chain 36.6's salary, the management and board of directors tenure and is there insider trading?


CEO

Vladimir Kintsurashvili (52yo)

0yrs

Tenure

0

Mr. Vladimir Vazhaevich Kintsurashvili serves as General Director & Chairman of the Management Board at Open Joint Stock Company Pharmacy Chain 36.6. Mr. Kintsurashvili served as a General Manager of Open ...


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.7%.


Management Team

  • Ruslan Nasybullin

    Chief Operational Officer

    • Tenure: 0yrs
  • Ekaterina Esinevich

    Chief Financial Officer

    • Tenure: 0yrs
  • Vladimir Kintsurashvili (52yo)

    General Director & Chairman of the Management Board

    • Tenure: 0yrs
  • Gusarov Igorevich (42yo)

    Director of Corporate Finance & Member of the Management Board

    • Tenure: 0yrs
  • Ivan Saganelidze (51yo)

    First Deputy General Director

    • Tenure: 0yrs
  • Bicherkharov Ramazanovich (38yo)

    General Director & Member of the Management Board

    • Tenure: 0yrs
  • Fogel Henriys (56yo)

    Member of the Management Board

    • Tenure: 0yrs
  • Deryabina Anatolyevna (47yo)

    Member of the Management Board

    • Tenure: 0yrs
  • Kherianov Tamazovich (46yo)

    Member of the Management Board

    • Tenure: 0yrs
  • Prokhorenko Yuryevich (34yo)

    Member of the Management Board

    • Tenure: 0yrs

Board Members

  • Kirilkin Sergeyevich (33yo)

    Director

    • Tenure: 0yrs
  • Sergey Yuryevich (46yo)

    Director

    • Tenure: 0yrs
  • Aleksey Abolyayev

    Director

    • Tenure: 0yrs
  • Vladimir Nesterenko

    Director

    • Tenure: 0yrs
  • Oksana Tarasova

    Director

    • Tenure: 0yrs
  • Oleg Fatuyev

    Director

    • Tenure: 0yrs
  • Pavel Shadrin

    Director

    • Tenure: 0yrs
  • Svetlana Afonchenko

    Member of Audit Commission

    • Tenure: 0yrs
  • Olga Korsunskaya

    Member of Audit Commission

    • Tenure: 0yrs
  • Ilya Levin

    Member of Audit Commission

    • Tenure: 0yrs

Company Information

Public Joint-Stock Company Pharmacy Chain 36.6's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Public Joint-Stock Company Pharmacy Chain 36.6
  • Ticker: APTK
  • Exchange: MISX
  • Founded: 1991
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: ₽79.506b
  • Shares outstanding: 6.71b
  • Website: https://pharmacychain366.ru

Location

  • Public Joint-Stock Company Pharmacy Chain 36.6
  • St. Vasilisa Kozhina, 1
  • Moscow
  • 121096
  • Russia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
APTKMISX (Micex - Rts)YesOrdinary SharesRURUBFeb 2004

Biography

Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. Its pharmacies offer health and beauty products. The company serves customers under the 36.6 brand name in the regions of Mosco ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/18 21:24
End of Day Share Price2019/11/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.